ZA200800488B - New Salt III - Google Patents

New Salt III

Info

Publication number
ZA200800488B
ZA200800488B ZA200800488A ZA200800488A ZA200800488B ZA 200800488 B ZA200800488 B ZA 200800488B ZA 200800488 A ZA200800488 A ZA 200800488A ZA 200800488 A ZA200800488 A ZA 200800488A ZA 200800488 B ZA200800488 B ZA 200800488B
Authority
ZA
South Africa
Prior art keywords
new salt
salt iii
iii
new
salt
Prior art date
Application number
ZA200800488A
Other languages
English (en)
Inventor
Giovannini Julien
Josefsson Bo-Goeran
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37708913&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200800488(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200800488B publication Critical patent/ZA200800488B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4468Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
ZA200800488A 2005-08-02 2008-01-16 New Salt III ZA200800488B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0501769 2005-08-02

Publications (1)

Publication Number Publication Date
ZA200800488B true ZA200800488B (en) 2008-12-31

Family

ID=37708913

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200800488A ZA200800488B (en) 2005-08-02 2008-01-16 New Salt III

Country Status (16)

Country Link
US (1) US20080176902A1 (xx)
EP (1) EP1912944A1 (xx)
JP (1) JP2009503066A (xx)
KR (1) KR20080031370A (xx)
CN (1) CN101238104A (xx)
AR (1) AR056013A1 (xx)
AU (1) AU2006276346A1 (xx)
BR (1) BRPI0614535A2 (xx)
CA (1) CA2617406A1 (xx)
IL (1) IL188484A0 (xx)
MX (1) MX2008001114A (xx)
NO (1) NO20081079L (xx)
TW (1) TW200734305A (xx)
UY (1) UY29713A1 (xx)
WO (1) WO2007015668A1 (xx)
ZA (1) ZA200800488B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR028948A1 (es) * 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
TW200738634A (en) * 2005-08-02 2007-10-16 Astrazeneca Ab New salt
GB0814729D0 (en) * 2008-08-12 2008-09-17 Argenta Discovery Ltd New combination

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1131290B1 (en) * 1998-11-20 2008-02-20 F. Hoffmann-La Roche Ag Piperidine ccr-3 receptor antagonists
CO5300399A1 (es) * 2000-02-25 2003-07-31 Astrazeneca Ab Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
AR028947A1 (es) * 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
AR028948A1 (es) * 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
GB0021670D0 (en) * 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
SE0104251D0 (sv) * 2001-12-14 2001-12-14 Astrazeneca Ab Novel compounds
TW200303304A (en) * 2002-02-18 2003-09-01 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
AU2006276346A1 (en) 2007-02-08
NO20081079L (no) 2008-02-29
KR20080031370A (ko) 2008-04-08
MX2008001114A (es) 2008-03-11
US20080176902A1 (en) 2008-07-24
CN101238104A (zh) 2008-08-06
AR056013A1 (es) 2007-09-12
WO2007015668A1 (en) 2007-02-08
UY29713A1 (es) 2007-02-28
BRPI0614535A2 (pt) 2011-04-05
TW200734305A (en) 2007-09-16
IL188484A0 (en) 2008-04-13
CA2617406A1 (en) 2007-02-08
EP1912944A1 (en) 2008-04-23
JP2009503066A (ja) 2009-01-29

Similar Documents

Publication Publication Date Title
EP1961741A4 (en) M-CARBAZOLYLPHENYL COMPOUNDS
HU0500920D0 (en) New compounds
HK1121755A1 (en) New compounds iii
HU0500921D0 (en) New compounds
EP1934217A4 (en) NEW COMPOUNDS II
HU0600293D0 (en) New rosuvastatine salt
AP2007004220A0 (en) Motilide compounds
ZA200800365B (en) Substituted tetrahydroqulnolines
EP1907385A4 (en) LINKS
ZA200800522B (en) New salt II
GB0506800D0 (en) New uses
GB0518232D0 (en) New methods
ZA200800488B (en) New Salt III
ZA200800515B (en) New Salt I
HU0501168D0 (en) New compounds
HU0501170D0 (en) New compounds
HU0500886D0 (en) New compounds
HU0500877D0 (en) New compounds
HU0500879D0 (en) New compounds
EP1951694A4 (en) FORMS OF SALTS
ZA200803275B (en) Compounds
EP1867650A4 (en) HYDROXYMETHYLBORVERBINDUNGEN
HU0501166D0 (en) New compounds
HU0500878D0 (en) New compounds
GB0425955D0 (en) Salt form